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BRIEF COMMUNICATION
PROTECTIVE EFFECT OF THE PROBIOTIC Saccharomyces boulardii IN Toxocara canis  
INFECTION IS NOT DUE TO DIRECT ACTION ON THE LARVAE
Luciana Farias da Costa de AVILA(1), Paula de Lima TELMO(2), Lourdes Helena Rodrigues MARTINS(3), Thaís Aimeé GLAESER(3),  
Fabricio Rochedo CONCEIÇÃO(2), Fábio Pereira Leivas LEITE(1) & Carlos James SCAINI(4)
SUMMARY
In a previous study our group found that the probiotic Saccharomyces boulardii was capable of reducing the intensity of infection 
in mice with toxocariasis. In order to assess whether the mechanism involved would be a direct action of the probiotic on Toxocara 
canis larvae, this study was designed. Both probiotics were singly cultivated in plates containing RPMI 1640 medium and T. canis 
larvae. S. boulardii and B. cereus var. toyoi cultures presented 97.6% and 95.7% of larvae with positive motility, respectively, and 
absence of color by the dye trypan blue, not representing significant difference to the control group (p > 0.05). We conclude that 
none of the probiotics showed in vitro effects on T. canis larvae and that the interaction with the intestinal mucosa is necessary for 
the development of the protective effect of S. boulardii.
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Visceral toxocariasis is a chronic parasitic disease of worldwide 
distribution12 currently regarded as a public health problem17. This 
parasitosis, commonly caused by the nematode Toxocara canis, is 
characterized by the migration and presence of the parasite larvae in 
humans. These parasites develop in the intestines of dogs, definitive 
hosts, that contaminate the soil with the parasite eggs. Humans and 
other paratenic hosts, such as mice, rats, chickens, lambs, and pigs, 
among others, acquire toxocariasis by ingesting T. canis eggs containing 
the infective-stage larvae9. The larvae hatch in the small intestine, 
where they perforate the wall and are disseminated by the systemic 
circulation14. 
The various clinical forms of human toxocariasis complicate 
treatment, making necessary the search for new alternatives of control 
and treatment. Although several studies have shown the benefit of the 
use of probiotics for the prevention and treatment of diseases, few have 
been conducted to evaluate the preventive effect on protozoosis10,13,15 and 
helminthiasis1,2,3. The Saccharomyces boulardii, yeast characterized as 
anti-inflammatory and immunostimulant in the intestinal mucosa3, is also 
related to the reduction of parasite burden in mice infected with T. canis1, 
although the mechanism of action is unknown. Besides this fungus, the 
Bacillus cereus var. toyoi is a probiotic related to the stimulation of the 
immune response and promotes animal weight gain7,8,11. There is still 
a gap in the understanding of the mechanism of action of these and 
other probiotics. In the present study, we evaluated whether there is any 
larvicidal effect of the probiotics S. boulardii and B. cereus var. toyoi 
on T. canis larvae in vitro. 
T. canis eggs were collected directly from the uterine tubes of adult 
gravid female parasites obtained after the treatment of puppies with 
pyrantel pamoate (15 mg/kg). Afterwards, the eggs were incubated in 2% 
formalin solution at 28 °C, with humidity above 90% and oxygenation 
for 30 days. Then, the extraction of larvae was performed according to 
DE SAVIGNY (1975). This study was approved by the Ethics Committee 
on Animal Experimentation of the Universidade Federal de Pelotas.
The S. boulardii yeast was cultivated in the YPD (Yeast Peptone 
Dextrose) medium, which was incubated in an orbital agitator (150 rpm) 
at 37 °C for 48 h. B. cereus var. toyoi was cultivated in BHI (Brain Heart 
Infusion) medium and incubated at the same conditions for 24 h. The 
cultures were centrifuged at 4000 × g for 10 min at 4 °C, and the pellets 
were washed with phosphate buffered saline (PBS) and quantified by 
determining colony forming units (CFU). 
A culture in RPMI 1640 with L-glutamine was performed, 
supplemented with penicillin, streptomycin and fungizone (Invitrogen®), 
of 100 larvae/hole in microculture plates (96 holes - TPP®). S. boulardii 
or B. cereus var. toyoi probiotics were then added in triplicate, at 
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concentrations of 1.104, 1.105, 1.106 and 1.107 CFU/hole. The RPMI 
1640 has been used and works with these probiotics6,19 and this medium 
with antibiotics was checked and did not inhibit the probiotics in the 
concentrations used. Two controls were used, one with live larvae and 
another with dead larvae, both in triplicate, in the RPMI 1640 culture. 
In all wells the dye trypan blue was added as a marker of cell viability. 
Since dead larvae have no motility and present blue staining, the control 
of dead larvae was used as a standard to assist in the identification of 
larvae in this condition after in vitro test. The material was incubated 
for 48 hours at 37 °C with 5-10% CO2. Afterwards, the motility of the 
larvae was evaluated in a light microscope, considering alive those that 
presented positive motility and absence of trypan blue staining. The 
experiment was done twice, with similar results. Data was subjected to 
an analysis of variance, and the means were compared with Tukey’s test, 
with a significance level of 95%.
The number of recovered live larvae in treatments with S. boulardii 
or B. cereus var. toyoi, at all tested concentrations, did not present 
significant difference for the control of live larvae. An average viability 
of 97.6% and 95.7% (p > 0.05) was observed for the treatment with S. 
boulardii and B. cereus var. toyoi, respectively (Table 1). In the control 
of live larvae an average viability of 96.5% was observed, with triplicate 
values of 95.9%, 96.7% and 97.0%. In the control of dead larvae, all of 
them were unviable and stained with trypan blue. The incubation time 
of 48 h was used because in just two days of infection it was already 
possible to observe a reduction in the number of T. canis larvae in mice 
treated with S. boulardii1.
Despite the absence of in vitro larvicidal effect of these two probiotics 
on T. canis observed in this study, a recent work conducted by our team 
showed a 36.7% reduction in larval burden of mice infected with T. canis 
that received S. boulardii. Moreover, this probiotic reduced by 41.9% 
the average number of larvae recovered from the liver1, demonstrating 
that such a probiotic promoted an important reduction in the intensity of 
the infection by T. canis larvae. Regarding the probiotic B. cereus var. 
toyoi, there are no reports of study in experimental models infected with 
T. canis, or other nematode, to do a comparison. 
Interesting results were obtained with the probiotic Lactobacillus 
casei inoculated intraperitoneally in NIH mice once a week during six 
weeks. The authors report that this probiotic induces a total protection 
against Trichinella spiralis infection at low doses16. Similar results were 
obtained in BALB/c mice with inhibited T. spiralis infections and invasion 
of the intestinal mucosa18. Regarding toxocariasis, CHIODO et al. (2010) 
showed that the CECT7121 probiotic strain of Enterococcus faecalis 
presented direct action on T. canis once it caused the death of in vitro 
larvae after 48-hour incubation. According to this author, the inhibitory 
activity obtained from the in vivo experiments was lower than in vitro, 
indicating a loss of the inhibitory effect of E. faecalis in the intestinal 
lumen; precisely the opposite of what we observed with S. boulardii, 
which increases its effect on the intestinal mucosa. 
From these results we can conclude that the contact of the S. 
boulardii yeast with the intestinal mucosa of the host is necessary for 
the development of their action on T. canis larvae and the mechanism 
of action is not a direct effect of the probiotics on the parasite. All 
these results suggest that the larvicidal effect and the mechanism of 
action developed on T. canis larvae varies according to the probiotic 
used. The use of probiotics for the control of parasitic diseases has 
shown promising results and further studies should be conducted in 
order to analyze the effect of other probiotics on T. canis larvae and 
other nematodes. 
RESUMO
Efeito protetor do probiótico Saccharomyces boulardii na infecção 
por Toxocara canis não se deve à ação direta sobre as larvas
Em estudo prévio nosso grupo verificou que o probiótico 
Saccharomyces boulardii foi capaz de reduzir a intensidade de infecção 
em camundongos com toxocaríase. Este estudo foi elaborado com o 
objetivo de avaliar se o mecanismo envolvido seria uma ação direta do 
probiótico sobre as larvas de Toxocara canis. Ambos probióticos foram 
cultivados, separadamente, em placas com meio RPMI1640 e larvas de 
T. canis. As culturas com S. boulardii e B. cereus var. toyoi apresentaram, 
respectivamente, 97,6% e 95,7% das larvas com motilidade positiva e 
ausência de coloração pelo azul de tripan, não representando diferença 
significativa do controle (p > 0,05). Concluímos que nenhum dos 
probióticos apresentou efeito in vitro sobre as larvas de T. canis e que a 
interação com a mucosa intestinal é necessária para o desenvolvimento 
do efeito protetor de S. boulardii.
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